Joel Beatty

Joel Beatty

#172 out of 1697 analysts
Baird
Automatically Tracked
Tracking: 0 Updated: Aug 06 at 01:21 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
62.08%
Gain
Monthly
1.16%
Yearly
14.79%
Drawdown
48.63%
$333,556.49
Equity
Holdings
$333,556.49
Cash
$0
Investment
$325,970.07
$233,556.49
Profit
Realized
$225,970.07
Unrealized
$7,586.42
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
$0
Win %
66%
This Week
Compared To Last Week
Gain
-0.8%
Profit
-$2,678.18
Win %
65%
This Month
Compared to last month
Gain
-0.8%
Profit
-$2,678.18
Win %
65%
This Year
Compared to last year
Gain
38.5%
Profit
$92,719.2
Win %
57%
Jazz Pharmaceuticals plc logo
JAZZ Jazz Pharmaceuticals plc
0%
$0
Larimar Therapeutics Inc. logo
LRMR Larimar Therapeutics Inc.
-7.06%
-$12,198.16
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
837
Longs Won
439/832 52%
Profit Factor
1.48
Profitability
Shorts Won
3/5 60%
Standard Deviation
$4,685.32
Average Win
$1,631.51
Best Trade
(Jun 02) $56,321.62
Sharpe Ratio
-81.9
Average Loss
-$1,234.35
Worst Trade
(Apr 15) -$44,770.14
Z-Score
-5.39 (100%)
Commissions
$0
Avg. Trade Length
1m 3w 1d
Expectancy
$279.04
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% 0.04% 0.29% 1.35% 4.96% 15.26% 41.17%
Consecutive Losing Trades 270 243 216 189 162 135 108 81 54 27
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV